Colonization Versus Carriage of Clostridium difficile

被引：75

作者：

Donskey, Curtis J. ^{[1
]}

Kundrapu, Sirisha ^{[2
]}

Deshpande, Abhishek ^{[3
]}

机构：

[1] Louis Stokes Cleveland Vet Affairs Med Ctr, Infect Dis Sect, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA

[3] Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2015年 / 29卷 / 01期

关键词：

Clostridium difficile; Colonization; Antibiotic; Transmission; VOLATILE FATTY-ACIDS; NOSOCOMIAL ACQUISITION; ASYMPTOMATIC CARRIAGE; RISK-FACTORS; BILE-SALTS; INFECTION; TRANSMISSION; VANCOMYCIN; SPORES; PREVALENCE;

D O I：

10.1016/j.idc.2014.11.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Asymptomatic carriage of toxigenic strains of Clostridium difficile is common in health care facilities and the community. However, infection control efforts have traditionally focused almost entirely on symptomatic patients. There is now growing concern that asymptomatic carriers may be an underappreciated source of transmission. This article provides an overview of the pathogenesis and epidemiology of C difficile colonization, reviews the evidence that asymptomatic carriers shed spores and contribute to transmission, and examines practical issues related to prevention of transmission from carriers.

引用

页码：13 / +

页数：17

共 66 条

[1] Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
Abujamel, Turki
Cadnum, Jennifer L.
Jury, Lucy A.
Sunkesula, Venkata C. K.
Kundrapu, Sirisha
Jump, Robin L.
Stintzi, Alain C.
Donskey, Curtis J.
[J]. PLOS ONE, 2013, 8 (10):
[2] Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice
Adams, Daniel A.
Riggs, Michelle M.
Donskey, Curtis J.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) : 2674 - 2678
[3] Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage
Alasmari, Faisal
Seiler, Sondra M.
Hink, Tiffany
Burnham, Carey-Ann D.
Dubberke, Erik R.
[J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (02) : 216 - 222
[4] Lactobacillus delbrueckii ssp bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells
Banerjee, Pratik
Merkel, Glenn J.
Bhunia, Arun K.
[J]. GUT PATHOGENS, 2009, 1
[5] FECAL METRONIDAZOLE CONCENTRATIONS DURING ORAL AND INTRAVENOUS THERAPY FOR ANTIBIOTIC ASSOCIATED COLITIS DUE TO CLOSTRIDIUM-DIFFICILE
BOLTON, RP
CULSHAW, MA
[J]. GUT, 1986, 27 (10) : 1169 - 1172
[6] Screening for carriage and nosocomial acquisition of Clostridium difficile by culture:: a study of 284 admissions of elderly patients to six general hospitals in Wales
Brazier, JS
Fitzgerald, TC
Hosein, I
Cefai, C
Looker, N
Walker, M
Bushell, AC
Rooney, P
[J]. JOURNAL OF HOSPITAL INFECTION, 1999, 43 (04) : 317 - 319
[7] Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, Charlie G.
Pamer, Eric G.
[J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (11) : 790 - 801
[8] PRESENCE OF CLOSTRIDIUM-DIFFICILE AND ANTIBIOTIC AND BETA-LACTAMASE ACTIVITIES IN FECES OF VOLUNTEERS TREATED WITH ORAL CEFIXIME, ORAL CEFPODOXIME PROXETIL, OR PLACEBO
CHACHATY, E
DEPITRE, C
MARIO, N
BOURNEIX, C
SAULNIER, P
CORTHIER, G
ANDREMONT, A
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 2009 - 2013
[9] ACQUISITION OF CLOSTRIDIUM-DIFFICILE BY HOSPITALIZED-PATIENTS - EVIDENCE FOR COLONIZED NEW ADMISSIONS AS A SOURCE OF INFECTION
CLABOTS, CR
JOHNSON, S
OLSON, MM
PETERSON, LR
GERDING, DN
[J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) : 561 - 567
[10] Acidified nitrite: a host defence against colonization with C. difficile spores?
Cunningham, R.
Mustoe, E.
Spiller, L.
Lewis, S.
Benjamin, N.
[J]. JOURNAL OF HOSPITAL INFECTION, 2014, 86 (02) : 155 - 157

← 1 2 3 4 5 6 7 →